ReviewDer Orthopade2019
[Slipped capital femoral epiphysis-etiology and pathogenesis].
Review in Der Orthopade, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 16 citations in OpenAlex.
- [Hip disorders in children and adolescents-an overview].Orthopadie (Heidelberg, Germany) · 2026Review
- Internal diseases and molecular mechanisms causing slipped capital femoral epiphysis in children.World journal of orthopedics · 2025Review
- Analysis of risk factors for difficult implant removal in children with slipped capital femoral epiphysis treated by cannulated screws.Frontiers in pediatrics · 2024Article
- [Evaluation of care for slipped capital femoral epiphysis (SCFE) in Germany].Orthopadie (Heidelberg, Germany) · 2024Article
- [Apophyseal avulsion in the pelvic region in childhood and adolescence].Der Unfallchirurg · 2021Review
- Slipped capital femoral epiphysis: an epidemiological Nationwide study in Italy from 2001 to 2015.BMC musculoskeletal disorders · 2021Article
- Total hip arthroplasty in patients with slipped capital femoral epiphysis: a systematic analysis of 915 cases.Orthopedic reviews · 2020Article
- A POST-TREATMENT RETROSPECTIVE EVALUATION OF SLIPPED CAPITAL FEMORAL EPIPHYSIS.Acta ortopedica brasileiraArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSlipped capital femoral epiphysis (SCFE) is the most significant hip disease in adolescence. Because of its typical occurrence at the time of the pubertal growth spurt and some particular clinical symptoms, it has been a topic of special interest in orthopedic research for a long time. A large number of etiological factors have been described, however their meaning in detail is still controversial.
objectivesAfter a short summary of the structure and function of the epiphysis, an overview of concepts in the pathogenesis of SCFE is given. MATERIALS AND
methodsA selective review of literature was performed.
resultsEtiology of SCFE includes genetic, endocrinologic, histochemical and biomechanical factors. During puberty, obesity together with reduced femoral antetorsion are the main risk factors for the disease. The rarer atypical SCFE is closely related to metabolic disorders or other chronical diseases. The pathogenesis is characterized by the disproportion between the load-bearing capacity of the epiphysis and the acting forces on the proximal femur.
conclusionsThe concept of the multifactorial etiology of SCFE is convincing. The susceptibility of the femoral epiphysis is explained considering the remarkable biomechanic local forces. The initial damage can be shown on the histological and the histochemical level. Important new aspects refer to the leptin-metabolism. However, in the majority of cases, biomechanical factors seem to be more significant than endocrinological phenomena. A complete understanding has not succeeded to date.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.